insulin

Launches a nationwide community-service digital portal for its employees to contribute to society

A statement from the company claimed that besides its employees, all its consultants, suppliers and partners are also bound by a…

Civica, launched in 2018 to make generic drugs, said it would produce three copycat versions of insulin

The 70:30 Joint Venture will primarily engage in marketing and distribution of human and analogue insulin including Aspart,…

The partnership coincides with the start of the centenary celebrations of the discovery of insulin

Also recommends inclusion of different formulations of insulin in the upcoming NLEM

Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.

Consistent, life-long access to insulin is imperative to patient survival and quality of life, says American pediatrician Adm…

The announcement was made at an United Nations General Assembly (UNGA) side meeting on innovation and universal health access…

As per the USFDA, a Complete Response Letter (CRL) is sent to an applicant if the agency determines that it will not approve the…